I met with a Rad Onc at Yale (New Haven, CT) on Oct. 15 just to get a dialogue started in case treatment becomes necessary. In short, our discussion led to the conclusion that for a patient with my stats (see signature below) the efficacy of SRT would be a "crapshoot". Seems to be due to the fact that I had negative surgical margins. As for side effects, he mentioned that the only one that is just about 100% unavoidable is ED. He told me that if the surgery didn't get you, the SRT surely will. In his experience, it is extremely rare for patients to escape unscathed in this department. He also mentioned that he always uses ADT in conjunction with SRT.
Bottom line is I'm no further along in my decision whether to start SRT or not. Still monitoring for now. Will go back to my Uro with another PSA test in early to mid-December.
Best wishes for good health to all,
Dx: in 6/2005 age 49, PSA 4.1, 2/10 cores pos, G6, T1c
bone scan: negative
daVinci RRP 8/2005, Hartford Hospital, Dr. Wagner
Post-surgery upgraded G7 (3+4), pT2c, NX,MX, neg. margins, perineural invasion present, tumor invades capsule wall, but not entirely through it.
PSA <0.1 until 4th yr post surgery, then 7/09 0.1, 10/09 0.2, 1/10 0.2, 2/10 0.14, 4/10 0.16,
8/10 0.25, 9/10 0.23